BRAF and colorectal carcinoma: These specific clinicopathological features support the hypothesis that the BRAF mutation-mediated carcinogenesis in CRC is initiated by altered BRAF function as an early step in the serrated pathway (Bennecke et al, 2010), leading to activation of RAF-MEK-ERK-MAP signalling.